WeVote
Log In

Bill

MD

Bill

A 3125

Limits perfluoroalkyl and polyfluoroalkyl substances in menstrual products.*

2026-2027 Regular Session Introduced by Mitchelle Drulis and 11 co-sponsors

New Jersey restricts PFAS chemicals in menstrual products to reduce repeated exposure to persistent contaminants linked to health risks.

Reported out of Assembly Comm. with Amendments, 2nd Reading
0
WeVote Research Nonpartisan
Bill Summary · A 3125

Legislative bill overview

Bill A 3125 restricts the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS)—a class of synthetic chemicals known as "forever chemicals"—in menstrual products sold in New Jersey. The bill requires manufacturers to disclose PFAS content and establishes limits on acceptable levels in these consumer products.

Why is this important

PFAS chemicals persist indefinitely in the environment and human body, accumulating over time and potentially causing health issues including immune system suppression, thyroid disease, and developmental effects. Menstrual products are used by millions of people regularly over decades, making them a direct and repeated exposure pathway for a vulnerable consumer group. This bill addresses a previously unregulated exposure route while setting a potential precedent for other states and product categories.

Potential points of contention

  • Manufacturing costs and availability: Reformulating products to eliminate PFAS may increase production costs and could temporarily limit product availability or selection in the state market
  • Scientific threshold questions: Determining what constitutes "safe" PFAS limits involves scientific debate; some argue any limit is arbitrary without federal guidance, while others contend precautionary action is warranted given PFAS persistence
  • Jurisdiction and interstate commerce: New Jersey's restrictions may create market fragmentation, forcing manufacturers to either reformulate nationwide or withdraw from the state, raising questions about state versus federal regulatory authority

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.